Filed
Pursuant to Rule 424(b)(2)
Registration
No. 333-289203
The
information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying
underlying supplement, prospectus supplement and prospectus are not an offer to sell these securities and we are not soliciting an offer
to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject
to Completion, Dated August 3, 2026
Pricing
Supplement dated , 2026
(To
Equity Index Underlying Supplement dated July 6, 2026, Prospectus Supplement dated
July 6, 2026, and Prospectus dated July 6, 2026)
| |
Marex
Group Limited
$
Autocallable Leveraged Barrier Notes Linked to the Worst Performing of the S&P 500® Index and the Nasdaq-100 Index®
due August 31, 2029
| ► | Callable
at the Principal Amount plus the Call premium of at least 14.25% (to be determined on the Trade
Date) of the Principal Amount if the Closing Level of each of the S&P 500® Index
and the Nasdaq-100 Index® (each, an “Underlying” and together, the “Underlyings”)
on the Call Observation Date on September 7, 2027 is at or above its Call Threshold (100% of its
Initial Value) |
| ► | If
the Notes are not called, at maturity: |
| o | 1.5x
upside exposure to any increases in the value of the Worst Performing Underlying |
| o | Return
of principal if the value of the Worst Performing Underlying does not change or decreases
by no more than 30% |
| o | 1-to-1
downside exposure to any decrease in the value of the Worst Performing Underlying if its
Reference Return is less than -30%, and in such a case, you will lose more than 30%, and
possibly all, of your Principal Amount |
| ► | Term: Approximately 3 years, if not
called |
| ► | All
payments on the Notes are subject to the credit risk of Marex Group Limited (“Marex”) |
Application
has been made for the Autocallable Leveraged Barrier Notes (the “Notes”) offered hereunder to be admitted to listing and
trading on the Vienna Multilateral Trading Facility (“Vienna MTF”) of the Vienna Stock Exchange. The Vienna MTF is not a
regulated market as defined by Directive 2014/65/EU (as amended, “MiFID II”). It is, however, a multilateral trading facility
(MTF) for purposes of MiFID II.
Neither
the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of
the Notes or passed upon the accuracy or the adequacy of this document or the accompanying prospectus, prospectus supplement or underlying
supplement. Any representation to the contrary is a criminal offense.
Any
offering of the Notes will be made pursuant to Article 1(4) of Regulation (EU) 2017/1129 (as amended), including as it forms part of
domestic law of the United Kingdom. Accordingly, no prospectus is required to be published in connection with such offering of the Notes
in any member state of the European Economic Area (the "EEA") or the United Kingdom (the "UK"). See page ii of the
accompanying prospectus supplement for further restrictions on offers and sales of the Notes in the EEA and the UK.
Investment
in the Notes involves certain risks. You should refer to “Risk Factors” beginning on page PS-7 of this document, page S-1
of the accompanying prospectus supplement and page S-1 of the accompanying underlying supplement.
The
Estimated Initial Value of the Notes on the Pricing Date is expected to be between $940.00 and $990.00 per Note, which will be less than
the price to public. The market value of the Notes at any time will reflect many factors and cannot be predicted with accuracy. See “Summary—Estimated
Initial Value” beginning on page PS-3 and “Risk Factors” beginning on page PS-7 of this document for additional information.
| |
Price
to Public |
Underwriting
Discount (1) |
Proceeds
to Issuer |
| Per
Note |
$1,000.00 |
|
|
| Total |
|
|
|
| (1) | Marex
Capital Markets Inc. (“MCMI”), an affiliate of ours, will act as the agent for
the sale of the Notes. MCMI will purchase the Notes from us at an underwriting discount of
up to $5.00 per $1,000 Principal Amount for distribution to other registered broker-dealers
or will offer the Notes directly to investors. MCMI will use the underwriting discount to
pay selling concessions or fees (including custodial or clearing fees) to other registered
broker-dealers. See “Supplemental Plan of Distribution (Conflicts of Interest)”
on page PS-13 of this document. |
The
Notes:
| Are
Not FDIC Insured |
Are
Not Bank Guaranteed |
May
Lose Value |
Marex
Capital Markets
SUMMARY
The
information in this “Summary” section is qualified by the more detailed information set forth in the underlying supplement,
the prospectus supplement and the prospectus. See “General” in this document.
| Issuer: |
Marex
Group Limited |
| Principal
Amount: |
$1,000
per Note |
| Reference
Asset: |
The
worst performing of the S&P 500® Index (Bloomberg symbol: SPX) (the “SPX”) and
the Nasdaq-100 Index® (Bloomberg symbol: NDX) (the “NDX”) |
| Trade
Date: |
August
28, 2026 |
| Pricing
Date: |
August
28, 2026 |
| Original
Issue Date: |
September
2, 2026 |
| Final
Valuation Date: |
August
28, 2029, subject to adjustment as described under “Additional
Terms of the Notes—Valuation Dates” in the accompanying underlying supplement. |
| Maturity
Date: |
August
31, 2029, subject to adjustment as described under “Additional
Terms of the Notes—Interest Payment
Dates, Coupon Payment Dates, Call Payment Dates and Maturity Date” in the accompanying underlying supplement. |
| Call
Feature: |
If
the Closing Level of each Underlying is at or above its Call Threshold on the Call Observation Date, the Notes will be automatically
called, and you will receive a cash payment, per $1,000 Principal Amount, equal to the Principal Amount plus the Call Premium on
the corresponding Call Payment Date. |
Call
Observation Date,
Call Payment Date, Call Premium and Call
Threshold: |
Call Observation Date* |
Call Payment Date* |
Call Premium (as % of the
Principal Amount) |
Call Threshold of each
Underlying (as % of its
Initial Value) |
| |
September 7, 2027 |
September 10, 2027 |
At least 14.25% (to be determined on the Trade Date) |
100.00% |
| |
*
Each subject to postponement as described under “Additional Terms of the Notes—Valuation Dates” and “Additional
Terms of the Notes—Interest Payment Dates, Coupon Payment Dates, Call Payment Dates and Maturity Date” in the accompanying
underlying supplement. |
| Payment
at Maturity: |
Unless
the Notes are automatically called, for each $1,000 Principal Amount, you will receive a cash payment on the Maturity Date, calculated
as follows:
<If
the Reference Return of the Worst Performing Underlying is greater than zero:
$1,000
+ ($1,000 × Reference Return of the Worst Performing Underlying × Upside Participation Rate)
<If
the Reference Return of the Worst Performing Underlying is less than or equal to zero but greater than or equal to the Barrier Percentage:
$1,000.
<If
the Reference Return of the Worst Performing Underlying is less than the Barrier Percentage:
$1,000
+ ($1,000 × Reference Return of the Worst Performing Underlying).
In
this case, you will lose 1% of the Principal Amount of your Notes for each percentage point that the Reference Return of the Worst Performing
Underlying is below zero. For example, if the Reference Return of the Worst Performing Underlying is -50.00%, you will suffer a 50% loss
and receive 50% of the Principal Amount, subject to the credit risk of Marex. If the Reference Return of the Worst Performing Underlying
is less than the Barrier Percentage, you will lose more than 30%, and possibly all, of your investment. |
| Upside
Participation Rate |
150% (1.50x) |
| Barrier
Percentage: |
-30% |
| Worst
Performing Underlying: |
The
Underlying with the lowest Reference Return. |
| Reference
Return: |
With
respect to each Underlying, the quotient, expressed as a percentage, calculated as follows:
Final
Value – Initial Value
Initial
Value |
| Initial
Value: |
With
respect to each Underlying, its Closing Level on the Pricing Date. |
| Final
Value: |
With
respect to each Underlying, its Closing Level on the Final Valuation Date. |
| CUSIP/ISIN: |
56653C2P9
/ US56653C2P96 |
| Form
of Notes: |
Book-Entry |
| Listing: |
Application
has been made for the Notes to be admitted to listing and trading on the Vienna MTF, a multilateral trading facility operated by
the Vienna Stock Exchange. |
| Estimated
Initial Value: |
The
Estimated Initial Value of the Notes is expected to be less than the price you pay to purchase the Notes. The Estimated Initial Value
does not represent a minimum price at which we or any of our affiliates would be willing to purchase your Notes in the secondary
market, if any, at any time. The Estimated Initial Value will be calculated on the Trade Date and will be set forth in the pricing
supplement to which this document relates. See “Risk Factors — The Estimated Initial Value of the Notes, which will be
determined by us on the Trade Date, is expected to be less than the price to public and may differ from the market value of the Notes
in the secondary market, if any.” |
| Calculation
Agent: |
Marex
Financial, one of our affiliates |
| |
|
The Trade
Date, the Pricing Date and the other dates set forth above are subject to change, and will be set forth in the pricing supplement relating
to the Notes.
GENERAL
This
document relates to an offering of Notes linked to the Reference Asset. The purchaser of a Note will acquire a senior unsecured debt
security of Marex. We reserve the right to withdraw, cancel or modify this offering and to reject orders in whole or in part. Although
the offering of Notes relates to the Reference Asset, you should not construe that fact as a recommendation as to the merits of acquiring
an investment linked to the Reference Asset or any security included in any Underlying or as to the suitability of an investment in the
Notes.
You
should read this document together with the prospectus dated July 6, 2026 (the “prospectus”), the prospectus supplement dated
July 6, 2026 (the “prospectus supplement”) and the Equity Index Underlying Supplement dated July 6, 2026 (the “underlying
supplement”). If the terms of the Notes offered hereby are inconsistent with those described in the accompanying prospectus, prospectus
supplement or underlying supplement, the terms described in this document shall control. You should carefully consider, among other things,
the matters set forth in “Risk Factors” beginning on page PS-7 of this document, page S-1 of the prospectus supplement and
page S-1 of the underlying supplement, as the Notes involve risks not associated with conventional debt securities. We urge you to consult
your investment, legal, tax, accounting and other advisors before you invest in the Notes. As used herein, references to the “Issuer”,
“Marex”, “we”, “us” and “our” are to Marex Group Limited. References to “Index”
or “Worst Performing Index” in the underlying supplement will be references to “Underlying” or “Worst Performing
Underlying” in this document. Certain terms used but not defined herein will have the meanings set forth in the underlying supplement,
the prospectus supplement or the prospectus.
You may access
the underlying supplement, the prospectus supplement and the prospectus on the SEC website www.sec.gov as follows (or if such address
has changed, by reviewing our filing for the relevant date on the SEC website):
| 🞂 | The
underlying supplement at: https://www.sec.gov/Archives/edgar/data/1997464/000119312526295601/d149086d424b2.htm |
| 🞂 | The
prospectus supplement at: https://www.sec.gov/Archives/edgar/data/1997464/000119312526295582/d135207d424b2.htm |
| 🞂 | The
prospectus at: https://www.sec.gov/Archives/edgar/data/1997464/000119312526295577/d124247d424b3.htm |
We are using
this document to solicit from you an offer to purchase the Notes. You may revoke your offer to purchase the Notes at any time prior to
the time at which we accept your offer by notifying MCMI. We reserve the right to change the terms of, or reject any offer to purchase,
the Notes prior to their issuance. In the event of any material changes to the terms of the Notes, we will notify you.
PAYMENT
ON THE NOTES
Call Feature
If
the Closing Level of each Underlying is at or above its Call Threshold on the Call Observation Date, the Notes will be automatically
called, and you will receive a cash payment, per $1,000 Principal Amount, equal to the Principal Amount plus the Call Premium on the
Call Payment Date.
Payment
at Maturity
Unless
the Notes are automatically called, on the Maturity Date, for each $1,000 Principal Amount of the Notes, we will pay you the Payment
at Maturity, which is an amount in cash, calculated as follows:
| < | If
the Reference Return of the Worst Performing Underlying is greater than zero: |
$1,000
+ ($1,000 × Reference Return of the Worst Performing Underlying × Upside Participation Rate)
| < | If
the Reference Return of the Worst Performing Underlying is less than or equal to zero but
greater than or equal to the Barrier Percentage: |
$1,000
(zero return).
| < | If
the Reference Return of the Worst Performing Underlying is less than the Barrier Percentage: |
$1,000
+ ($1,000 × Reference Return of the Worst Performing Underlying).
In
this case, you will lose 1% of the Principal Amount of your Notes for each percentage point that the Reference Return of the Worst Performing
Underlying is below zero. For example, if the Reference Return of the Worst Performing Underlying is -50.00%, you will suffer a 50% loss
and receive 50% of the Principal Amount, subject to the credit risk of Marex. If the Reference Return of the Worst Performing Underlying
is less than the Barrier Percentage, you will lose more than 30%, and possibly all, of your investment.
Interest
The
Notes will not pay interest.
INVESTOR
SUITABILITY
The
Notes may be suitable for you if:
| ► | You
are a retail investor outside the EEA and the UK or an institutional buyer (for restrictions
on offers or sales to retail investors in the EEA and the UK, please see page ii of the accompanying
prospectus supplement). |
| ► | You
are an investor with the competence (either independently or with the support of a financial
advisor) to assess the suitability of this investment based on your individual circumstances. |
| ► | You
have the necessary knowledge and/or experience with structured products and are prepared
to accept the corresponding risks. |
| ► | You
seek (i) the Call Premium, which will be payable if the Closing Level of each Underlying
on the Call Observation Date is greater than or equal to its Call Threshold; or (ii) an investment
with an enhanced return linked to the potential positive performance of the Worst Performing
Underlying and you believe that the value of each Underlying will increase over the term
of the Notes. |
| ► | You
are willing to make an investment that is exposed to the potential downside performance of
the Worst Performing Underlying on a 1-to-1 basis if the Notes are not called and the Reference
Return of the Worst Performing Underlying is less than the Barrier Percentage. |
| ► | You
are willing to lose up to 100% of the Principal Amount. |
| ► | You
understand that the return on the Notes will depend solely on the performance of the Worst
Performing Underlying and consequently, the Notes are riskier than alternative investments
linked to only one of the Underlyings or linked to a basket composed of the Underlyings. |
| ► | You
are willing to hold the Notes which will be automatically called on the Call Observation
Date on which the Closing Level of each Underlying is at or above its Call Threshold, or
you are otherwise willing to hold the Notes to maturity. |
| ► | You
are willing to forgo the dividends or other distributions paid on the stocks included in
the Underlyings. |
| ► | You
do not seek current income from your investment. |
| ► | You
do not seek an investment for which there will be an active secondary market. |
| ► | You
are willing to accept the risk and return profile of the Notes versus a conventional debt
security with a comparable maturity issued by Marex or another issuer with a similar credit
rating. |
| ► | You
are comfortable with the creditworthiness of Marex, as Issuer of the Notes. |
The
Notes may not be suitable for you if:
| ► | You
are a retail investor in the EEA or the UK (for restrictions on offers or sales to retail
investors in the EEA and the UK, please see page ii of the accompanying prospectus supplement). |
| ► | You
are an investor without the competence (either independently or with the support of a financial
advisor) to assess the suitability of this investment based on your individual circumstances. |
| ► | You
do not have the necessary knowledge and/or experience with structured products and are not
prepared to accept the corresponding risks. |
| ► | You
believe that (i) the Closing Level of each Underlying will be less than its Call Threshold
on the Call Observation Date; and (ii) the Reference Return of the Worst Performing Underlying
will be negative or it will not be sufficiently positive to provide you with your desired
return. |
| ► | You
are unwilling to make an investment that is exposed to the potential downside performance
of the Worst Performing Underlying on a 1-to-1 basis if the Notes are not called and the
Reference Return of the Worst Performing Underlying is less than the Barrier Percentage. |
| ► | You
seek an investment that provides full return of principal. |
| ► | You
seek exposure to a basket composed of the Underlyings or a similar investment in which the
overall return is based on a blend of the performances of the Underlyings, rather than solely
on the Worst Performing Underlying. |
| ► | You
are unable or unwilling to hold the Notes that will be automatically called on the Call Observation
Date on which the Closing Level of each Underlying is at or above its Call Threshold, or
you are otherwise unable or unwilling to hold the Notes to maturity. |
| ► | You
prefer to receive the dividends or other distributions paid on the stocks included in the
Underlyings. |
| ► | You
seek current income from your investment. |
| ► | You
seek an investment for which there will be an active secondary market. |
| ► | You
prefer the lower risk, and therefore accept the potentially lower returns, of conventional
debt securities with comparable maturities issued by Marex or another issuer with a similar
credit rating. |
| ► | You
are not willing or are unable to assume the credit risk associated with Marex, as Issuer
of the Notes. |
RISK
FACTORS
We
urge you to read the section “Risk Factors” beginning on page S-1 of the accompanying prospectus supplement and page S-1
of the accompanying underlying supplement. You should understand the risks of investing in the Notes and should reach an investment decision
only after careful consideration, with your advisors, of the suitability of the Notes in light of your particular financial circumstances
and the information set forth in this document and the accompanying prospectus, prospectus supplement and underlying supplement.
In
addition to the risks discussed below, you should review “Risk Factors” in the accompanying prospectus supplement and underlying
supplement including the explanation of risks relating to the Notes described in the following sections:
►
“—Risks Related to Note Issuances” in the prospectus
supplement; and
►
“—General risks related to an Index” in the underlying
supplement.
You
will be subject to significant risks not associated with conventional fixed-rate or floating-rate debt securities.
Risks
Relating to the Structure or Features of the Notes
You
may lose some or all of the principal at maturity.
The
Notes do not guarantee any return of principal. The Notes differ from ordinary debt securities in that we will not pay you 100% of the
Principal Amount of your Notes if the Notes are not called and the Reference Return of the Worst Performing Underlying is less than the
Barrier Percentage. In this case, the Payment at Maturity you will be entitled to receive will be less than the Principal Amount and
you will lose 1% for each 1% that the Reference Return of the Worst Performing Underlying is less than 0.00%. You may lose up to 100%
of your investment at maturity.
If
the Notes are called, your return on the Notes will be limited to the Call Premium, regardless of any appreciation in the value of any
Underlying.
If
the Notes are called prior to maturity, the return on the Notes will equal the Call Premium, regardless of any appreciation in the value
of any Underlying, which may be significant. Accordingly, the return on the Notes may be significantly less than the return on a direct
investment in the stocks included in the Underlyings during the term of the Notes.
The
Notes may be called prior to maturity, and the Notes are subject to reinvestment risk.
If
the Notes are called early, the holding period could be as little as approximately 12 months. There is no guarantee that you would be
able to reinvest the proceeds from an investment in the Notes at a comparable return for a similar level of risk in the event the Notes
are called prior to the Maturity Date.
The
amount payable on the Notes is not linked to the values of the Underlyings at any time other than on the Call Observation Date and the
Final Valuation Date.
The
payments on the Notes will be based on the Closing Levels of the Underlyings on the Call Observation Date and the Final Valuation Date,
each subject to postponement for non-trading days and certain Market Disruption Events. Even if the value of each Underlying increases
during the term of the Notes other than on the Call Observation Date and the Final Valuation Date but decreases on those days to a value
that is less than its Initial Value, the Notes will not be automatically called and the Payment at Maturity will be less, possibly significantly
less, than it would have been had the payment on the Notes been linked to the values of the Underlyings other than such decrease. Although
the actual values of the Underlyings on the Maturity Date or at other times during the term of the Notes may be higher than the Closing
Levels of the Underlyings on the Call Observation Date and the Final Valuation Date, the payment on the Notes will be based solely on
the Closing Levels of the Underlyings on the Call Observation Date and the Final Valuation Date.
The
Notes are subject to the full risks of the Worst Performing Underlying and will be negatively affected if any Underlying performs poorly,
even if the other Underlyings perform favorably.
You
are subject to the full risks of the Worst Performing Underlying. If the Worst Performing Underlying performs poorly, you will be negatively
affected, even if the other Underlyings perform favorably. The Notes are not linked to a basket composed of the Underlyings, where the
better performance of one Underlying could offset the poor performance of the others. Instead, you are subject to the full risks of the
Worst Performing Underlying on the Final Valuation Date. As a result, the Notes are riskier than an alternative investment linked to
only one of the Underlyings or linked to a basket composed of the Underlyings. You should not invest in the Notes unless you understand
and are willing to accept the full downside risks of the Worst Performing Underlying
The
Notes will not bear interest.
As
a holder of the Notes, you will not receive interest payments.
Risks
Relating to the Reference Asset
Changes
that affect an Underlying may affect the value of that Underlying and the return on the Notes.
The
policies of the Reference Sponsor of an Underlying concerning additions, deletions and substitutions of the stocks included in that Underlying,
and the manner in which the Reference Sponsor takes account of certain changes affecting those stocks, may adversely affect the value
of that Underlying. The policies of the Reference Sponsor with respect to the calculation of an Underlying could also
adversely affect
the value of that Underlying. The Reference Sponsor may discontinue or suspend calculation or dissemination of an Underlying. Any such
actions could adversely affect the value of an Underlying and the value of and the return on the Notes.
The
Notes are subject to non-U.S. Securities Risk.
Some
of the equity securities included in the NDX are issued by non-U.S. companies. Investments in securities linked to the value of such
non-U.S. equity securities, such as the Notes, involve risks associated with the home countries of the issuers of those non-U.S. equity
securities. The prices of securities in non-U.S. markets may be affected by political, economic, financial and social factors in those
countries, or global regions, including changes in government, economic and fiscal policies and currency exchange laws.
General
Risk Factors
The
Notes are subject to our credit risk.
Marex
may partially or wholly fail to meet their obligations under the Notes. Investors should therefore take the creditworthiness of Marex
and its subsidiaries into account in their investment decision. Credit risk means the risk of insolvency or illiquidity of an issuer,
i.e. a potential, temporary or final inability to fulfil their interest and repayment obligations on time. An increased insolvency risk
is typical of issuers that have a low creditworthiness. The payment of any amount due on the Notes is subject to the credit risk of Marex.
The Notes are senior unsecured debt obligations of Marex, and are not, either directly or indirectly, an obligation of any third party.
Investors are dependent on Marex’s ability to pay all amounts due on the Notes, and therefore investors are subject to the credit
risk of Marex and to changes in the market’s view of its creditworthiness
The
Notes are not bank deposits and are not insured or guaranteed by the U.S. Federal Deposit Insurance Corporation, the UK Financial Services
Compensation Scheme or any other government or governmental or private agency or deposit protection scheme in any jurisdiction. Investors
are dependent on Marex’s ability to pay all amounts due on the Notes, and therefore investors are subject to Marex’s credit
risk and to changes in the market’s view of Marex’s creditworthiness. The payment of any amount due on the Notes is not guaranteed
by any entity.
The
Notes are not insured against loss by any third parties; you can depend only on our earnings and assets for any payment on the Notes.
The
Notes will be solely our obligations, and no other entity will have any obligation, contingent or otherwise, to make any payments in
respect of the Notes.
The
Estimated Initial Value of the Notes, which will be determined by us on the Trade Date, is expected to be less than the price to public
and may differ from the market value of the Notes in the secondary market, if any.
The
Estimated Initial Value of the Notes will be calculated by us on the Trade Date and is expected to be less than the price to public.
The Estimated Initial Value will reflect our and our affiliates’ internal funding rate, which is the borrowing rate paid to issue
market-linked securities, as well as the mid-market value of the embedded derivatives in the Notes. This internal funding rate is typically
lower than the rate we would use when we issue conventional fixed or floating rate debt securities. As a result of the difference between
our internal funding rate and the rate we would use when we issue conventional fixed or floating rate debt securities, the Estimated
Initial Value of the Notes may be lower if it were based on the prices at which our fixed or floating rate debt securities trade in the
secondary market. In addition, if we were to use the rate we use for our conventional fixed or floating rate debt issuances, we would
expect the economic terms of the Notes to be more favorable to you. We will determine the value of the embedded derivatives in the Notes
by reference to our or our affiliates’ internal pricing models. These pricing models consider certain assumptions and variables,
which can include volatility and interest rates. Different pricing models and assumptions could provide valuations for the Notes that
are different from our Estimated Initial Value. These pricing models rely in part on certain forecasts about future events, which may
prove to be incorrect. The Estimated Initial Value does not represent a minimum price at which we or any of our affiliates would be willing
to purchase your Notes in the secondary market (if any exists) at any time.
The
price of your Notes in the secondary market, if any, immediately after the Trade Date is expected to be less than the price to public.
The
price to public takes into account certain costs. These costs include our affiliates’ projected hedging profits (which may or may
not be realized) for assuming risks inherent in hedging our obligations under the Notes, the underwriting discount and the costs associated
with structuring and hedging our obligations under the Notes. These costs will be used or retained by us or one of our affiliates, except
for underwriting discounts paid to unaffiliated distributors. If you were to sell your Notes in the secondary market, if any, the price
you would receive for your Notes may be less than the price you paid for them because secondary market prices will not take into account
these costs. The price of your Notes in the secondary market, if any, at any time after issuance will vary based on many factors, including
the values of the Underlyings and changes in market conditions, and cannot be predicted with accuracy. The Notes are not designed to
be short-term trading instruments, and you should, therefore, be able and willing to hold the Notes to maturity. Any sale of the Notes
prior to maturity could result in a loss to you.
If
we were to repurchase your Notes immediately after the Original Issue Date, the price you receive may be higher than the Estimated Initial
Value of the Notes.
Assuming
that all relevant factors remain constant after the Original Issue Date, the price at which MCMI may initially buy or sell the Notes
in the secondary market, if any, and the value that may initially be used for customer account statements, if any, may exceed the Estimated
Initial Value on the Trade Date for a temporary period expected to be approximately 6 months after the Original Issue Date. This temporary
price
difference may exist because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated
cost of hedging our obligations under the Notes and other costs in connection with the Notes that we will no longer expect to incur over
the term of the Notes. We will make such discretionary election and determine this temporary reimbursement period on the basis of a number
of factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated
costs which we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement period, and we
may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Original Issue Date of the
Notes based on changes in market conditions and other factors that cannot be predicted.
You
will not have any ownership interest in the stocks included in an Underlying.
As
a holder of the Notes, you will not have any ownership interest in the stocks included in an Underlying, such as rights to vote, dividend
payments or other distributions. Because the return on the Notes will not reflect any dividends on those stocks, the Notes may underperform
an investment in the stocks included in an Underlying.
The
Notes lack liquidity.
The
Notes are a new issue of securities for which there is no established market. Although we will apply for the Notes to be listed for trading
on the Vienna MTF, we cannot provide you with any assurance regarding whether the Notes will become or remain listed or whether a trading
market for the Notes will develop or as to the liquidity or sustainability of any such market, the ability of holders of the Notes to
sell their Notes or the price at which holders may be able to sell their Notes. The listing application will be subject to approval by
the Vienna Stock Exchange. There can be no assurance that application for listing and admission to trading will be granted or than an
active trading market in the Notes will develop. If such a listing is obtained, we have no obligation to maintain such listing, and we
may delist the Notes at any time. In addition, MCMI is not required to offer to purchase the Notes in the secondary market. Even if a
secondary market were to develop, it may not provide enough liquidity to allow you to trade or sell the Notes easily. Because other dealers
are not likely to make a secondary market for the Notes, the price at which you may be able to trade your Notes is likely to depend on
the price, if any, at which MCMI is willing to buy the Notes.
Potential
conflicts of interest may exist.
Marex
and its affiliates play a variety of roles in connection with the issuance of the Notes, including acting as calculation agent and hedging
our obligations under the Notes. Following the occurrence of certain events – relating to the Issuer, the Issuer's hedging arrangements,
the Underlying(s), taxation, the relevant currency or other matters – outside of the Issuer's control, the calculation agent may
determine in its discretion to take one of the actions available to it in order to deal with the impact of such event on the Notes or
the Issuer or both. These actions may include (i) adjustment to the terms and conditions of the Notes, (ii) substitution of the
Underlying(s) and/or (iii) early redemption or exercise of the Notes. In performing these duties, the economic interests of the calculation
agent and other affiliates of ours are potentially adverse to your interests as an investor in the Notes. Any such discretionary determination
by the Issuer or the calculation agent could have a negative impact on the value of the Notes. We will not have any obligation to consider
your interests as a holder of the Notes in taking any action that might adversely affect the value of your Notes.
Uncertain
tax treatment.
For
a discussion of the U.S. federal income tax consequences of your investment in a Note, please see the discussion under “U.S. Federal
Income Tax Considerations” herein, the discussion under “U.S. Federal Income Tax Considerations” in the accompanying
prospectus supplement and the discussion under “Material Tax Considerations — Material U.S. Federal Income Tax Considerations”
in the accompanying prospectus.
ILLUSTRATIVE
EXAMPLES
The
following table and examples are provided for illustrative purposes only and are hypothetical. They do not purport to be representative
of every possible scenario concerning increases or decreases in the Final Value of any Underlying relative to its Initial Value. We cannot
predict the Closing Level of any Underlying at any time during the term of the notes, including the Call Observation Date and the Final
Valuation Date. The assumptions we have made in connection with the illustrations set forth below may not reflect actual events. You
should not take this illustration or these examples as an indication or assurance of the expected performance of any Underlying or return
on the Notes. The numbers appearing in the table below and following examples have been rounded for ease of analysis.
The
table and examples below illustrate the Payment at Maturity on a $1,000 investment in the Notes for a hypothetical range of Reference
Returns of the Worst Performing Underlying from -100% to +100%. The following results are based solely on the assumptions outlined below.
The “Hypothetical Return on the Notes” as used below is the number, expressed as a percentage, that results from comparing
the Payment at Maturity per $1,000 Principal Amount to $1,000. The potential returns described below assume that the Notes have not been
automatically called prior to maturity and are held to maturity. The following table and examples assume the following:
| Principal
Amount: |
$1,000 |
| Upside
Participation Rate: |
150.00% |
| Barrier
Percentage: |
-30.00% |
| Hypothetical
Initial Value of the Worst Performing Underlying: |
1,000.00 |
Hypothetical
Final
Value of the Worst
Performing
Underlying |
Hypothetical
Reference Return
of the Worst Performing
Underlying |
Hypothetical
Payment at
Maturity |
Hypothetical
Return on
the Notes |
| 2,000.00 |
100.00% |
$2,500.00 |
150.00% |
| 1,800.00 |
80.00% |
$2,200.00 |
120.00% |
| 1,600.00 |
60.00% |
$1,900.00 |
90.00% |
| 1,400.00 |
40.00% |
$1,600.00 |
60.00% |
| 1,200.00 |
20.00% |
$1,300.00 |
30.00% |
| 1,100.00 |
10.00% |
$1,150.00 |
15.00% |
| 1,050.00 |
5.00% |
$1,075.00 |
7.50% |
| 1,020.00 |
2.00% |
$1,030.00 |
3.00% |
| 1,000.00(1) |
0.00% |
$1,000.00 |
0.00% |
| 900.00 |
-10.00% |
$1,000.00 |
0.00% |
| 800.00 |
-20.00% |
$1,000.00 |
0.00% |
| 700.00 |
-30.00%(2) |
$1,000.00 |
0.00% |
| 690.00 |
-31.00% |
$690.00 |
-31.00% |
| 600.00 |
-40.00% |
$600.00 |
-40.00% |
| 400.00 |
-60.00% |
$400.00 |
-60.00% |
| 200.00 |
-80.00% |
$200.00 |
-80.00% |
| 0.00 |
-100.00% |
$0.00 |
-100.00% |
| (1) | The
hypothetical Initial Value of 1,000 used in these examples has been chosen for illustrative
purposes only, and does not represent a likely actual Initial Value of any Underlying. |
| (2) | This
is the Barrier Percentage. |
The
following examples indicate how the Payment at Maturity would be calculated with respect to a hypothetical $1,000 investment in the Notes
assuming that the Notes have not been automatically called prior to maturity and are held to maturity.
Example
1: The Reference Return of the Worst Performing Underlying Is 10.00%.
Because
the Reference Return of the Worst Performing Underlying is greater than zero, the Payment at Maturity would be $1,150.00 per $1,000 Principal
Amount, calculated as follows:
$1,000
+ ($1,000 × Reference Return of the Worst Performing Underlying × Upside Participation Rate)
=
$1,000 + ($1,000 × 10.00% × 150.00%)
=
$1,150.00
Example
1 shows that the Notes provide a leveraged return if the Reference Return of the Worst Performing Underlying is positive.
Example
2: The Reference Return of the Worst Performing Underlying Is -5.00%.
Because
the Reference Return of the Worst Performing Underlying is less than or equal to zero but greater than or equal to the Barrier Percentage,
the Payment at Maturity would be $1,000.00 per $1,000 Principal Amount.
Example
2 shows that the Payment at Maturity will equal the Principal Amount if the Reference Return of the Worst Performing Underlying is less
than or equal to zero but greater than or equal to the Barrier Percentage, although the value of the Worst Performing Underlying has
decreased moderately.
Example
3: The Reference Return of the Worst Performing Underlying Is -80.00%.
Because
the Reference Return of the Worst Performing Underlying is less than the Barrier Percentage, the Payment at Maturity would be $200.00
per $1,000 Principal Amount, calculated as follows:
$1,000
+ ($1,000 × Reference Return of the Worst Performing Underlying)
=
$1,000 + ($1,000 × -80.00%)
=
$200.00
Example
3 shows that you are exposed on a 1-to-1 basis to any decrease in the value of the Worst Performing Underlying from its Initial Value
if its Reference Return is less than the Barrier Percentage. You may lose up to 100% of your Principal Amount at maturity.
DESCRIPTION
OF THE REFERENCE ASSET
Description
of the SPX
The
SPX is a capitalization-weighted index of 500 U.S. stocks. It is designed to measure performance of the broad domestic economy through
changes in the aggregate market value of 500 stocks representing all major industries.
For
more information about the SPX, see "Index Descriptions—The S&P U.S. Indices" beginning on page S-42 of the accompanying
underlying supplement.
|
|
Historical
Performance of the SPX
The
following graph sets forth the historical performance of the SPX based on the daily historical closing levels from July 30, 2021
through July 30, 2026. We obtained the closing levels
below from Bloomberg L.P. (“Bloomberg”). We have not undertaken any independent review of, or made any due diligence
inquiry with respect to, the information obtained from Bloomberg.
|
The
historical values of the SPX should not be taken as an indication of its future performance, and no assurance can be given as to
the Closing Level of the SPX on the Call Observation Date or the Final Valuation Date.
|
Description
of the NDX
The
NDX is a modified market capitalization-weighted index of 100 of the largest domestic and international non-financial companies listed
on The Nasdaq Stock Market based on market capitalization. It does not contain securities of financial companies, including investment
companies.
For
more information about the NDX, see " Index Descriptions—The Nasdaq-100 Index®" beginning on page
S-25 of the accompanying underlying supplement.
|
|
Historical
Performance of the NDX
The
following graph sets forth the historical performance of the NDX based on the daily historical closing levels from July 30, 2021
through July 30, 2026. We obtained the closing levels
below from Bloomberg. We have not undertaken any independent review of, or made any due diligence inquiry with respect to, the information
obtained from Bloomberg.
|
The
historical values of the NDX should not be taken as an indication of its future performance, and no assurance can be given as to the
Closing Level of the NDX on the Call Observation Date or the Final Valuation Date. |
SUPPLEMENTAL
PLAN OF DISTRIBUTION (CONFLICTS OF INTEREST)
We
have appointed MCMI, an affiliate of Marex, as the agent for the sale of the Notes. Pursuant to the terms of a distribution agreement,
MCMI will purchase the Notes from Marex at the price to public less the underwriting discount set forth on the cover page of the pricing
supplement to which this document relates, for distribution to other registered broker-dealers or will offer the Notes directly to investors.
MCMI proposes to offer the Notes at the price to public set forth on the cover page of this document. MCMI will use the underwriting
discount to pay selling concessions or fees (including custodial or clearing fees) to other registered broker-dealers.
An
affiliate of Marex has paid or may pay in the future an amount to broker-dealers in connection with the costs of the continuing implementation
of systems to support the Notes. We or one of our affiliates may pay a fee to one or more broker dealers for providing certain services
with respect to this offering, which may reduce the economic terms of the Notes to you.
In
addition, MCMI or another of our affiliates or agents may use the pricing supplement to which this document relates in market-making
transactions after the initial sale of the Notes, but is under no obligation to make a market in the Notes and may discontinue any market-making
activities at any time without notice.
See
“Supplemental Plan of Distribution (Conflicts of Interest)” on page S-61 in the prospectus supplement.
We
expect that delivery of the Notes will be made against payment for the Notes on or about the Original Issue Date set forth on the inside
cover page of this document, which is more than one business day following the Trade Date. Under Rule 15c6-1 under the Securities Exchange
Act of 1934, trades in the secondary market generally are required to settle in one business day, unless the parties to that trade expressly
agree otherwise. Accordingly, purchasers who wish to trade the Notes more than one business day prior to the Original Issue Date will
be required to specify an alternate settlement cycle at the time of any such trade to prevent a failed settlement, and should consult
their own advisors.
U.S.
FEDERAL INCOME TAX CONSIDERATIONS
The
U.S. federal income tax consequences of each holder’s investment in the Notes are uncertain. There are no Treasury Regulations,
published rulings or judicial decisions addressing the treatment for U.S. federal income tax purposes of securities with terms that are
substantially the same as the Notes. By purchasing the Notes, each holder agrees (in the absence of a change in law, an administrative
determination or a judicial ruling to the contrary) to treat each Note as a pre-paid executory contract for U.S. federal income tax purposes.
In the opinion of our counsel, Mayer Brown LLP, it would generally be reasonable to treat the Notes as pre-paid executory contracts in
respect of the Underlyings for U.S. federal income tax purposes.
In
addition, a U.S. Holder should generally recognize capital gain or loss upon
redemption, sale or maturity or other taxable disposition of such holder’s Notes in an amount
equal to the difference between the amount realized at such time and such holder’s tax
basis in such Notes. In general, a U.S. Holder’s tax basis in the Notes will equal the holder’s
cost for the Notes. Such gain or loss should generally be long-term capital gain or loss if a U.S. Holder has held the Notes for more
than one year (otherwise such gain or loss should be short-term capital gain or loss if held for one year or less). The deductibility
of capital losses is subject to limitations. U.S. Holders should consult their tax advisors regarding this risk.
The
U.S. federal income tax consequences of a U.S. Holder’s investment in the Notes are uncertain and the Internal Revenue Service
could assert that the Notes should be taxed in a manner that is different from that described above. Please see the discussion in the
accompanying prospectus supplement under “U.S. Federal Income Tax Considerations” and in particular the discussion under
"U.S. Federal Income Tax Considerations —U.S. Holders — Certain Notes Treated as a Put Option and a Deposit or an Executory
Contract — Certain Notes Treated as Executory Contracts” and the discussion in the accompanying prospectus under “Material
Tax Considerations — Material U.S. Federal Income Tax Considerations”.
Non-U.S.
Holders should review the discussion in the accompanying prospectus supplement under “U.S. Federal Income Tax Considerations —
Non-U.S. Holders” for a discussion of the U.S. federal income tax consequences applicable to Non-U.S. Holders.
A
“dividend equivalent” payment is treated as a dividend from sources within the United States and such payments generally
would be subject to a 30% U.S. withholding tax if paid to a Non-U.S. Holder. Under Treasury Regulations, payments (including deemed payments)
with respect to equity-linked instruments (“ELIs”) that are “specified ELIs” may be treated as dividend equivalents
if such specified ELIs reference an interest in an “underlying security,” which is generally any interest in an entity taxable
as a corporation for U.S. federal income tax purposes if a payment with respect to such interest could give rise to a U.S. source dividend.
However, IRS guidance provides that withholding on dividend equivalent payments will not apply to specified ELIs that are not delta-one
instruments and that are issued before January 1, 2027. We expect that the delta of the Notes will not be one, and therefore, we expect
that Non-U.S. Holders should not be subject to withholding on dividend equivalent payments, if any, under the Notes. However, it is possible
that the Notes could be treated as deemed reissued for U.S. federal income tax purposes upon the occurrence of certain events affecting
an Underlying or the Notes, and following such occurrence the Notes could be treated as subject to withholding on dividend equivalent
payments. Non-U.S. Holders that enter, or have entered, into other transactions in respect of an Underlying or the Notes should consult
their tax advisors as to the application of the dividend equivalent withholding tax in the context of the Notes and their other transactions.
If any payments are treated as dividend equivalents subject to withholding, we (or an applicable withholding agent) would be entitled
to withhold taxes without being required to pay any additional amounts with respect to amounts so withheld.
PROSPECTIVE
PURCHASERS OF THE NOTES SHOULD CONSULT THEIR TAX ADVISORS AS TO THE TAX CONSEQUENCES OF THE ABOVE DESCRIBED CHARACTERIZATION OF THE NOTES
AND ANY POSSIBLE ALTERNATIVE CHARACTERIZATIONS OF THE NOTES FOR U.S. FEDERAL INCOME TAX PURPOSES. PROSPECTIVE PURCHASERS OF NOTES SHOULD
CONSULT THEIR TAX ADVISORS AS TO THE FEDERAL, STATE, LOCAL, AND OTHER TAX CONSEQUENCES TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION
OF NOTES.